- Schoenfeld AJ
- Bensen GP
- Blucher JA
- Ferrone ML
- Balboni TA
- Schwab JH
- et al.
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Spine JournalReferences
- Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.Lancet. 2005; 366: 643-648
- Design of the prospective observational study of spinal metastasis treatment (POST).Spine J. 2020; 20: 572-579
- Rapid improvements in pain and quality of life are sustained after surgery for spinal metastases in a large prospective cohort.Br J Neurosurg. 2016; 30: 337-344
- Cost-utility analysis of surgery and radiotherapy for symptomatic spinal metastases in a belgian specialist center.World Neurosurg. 2019; 125: e537-e543
- Surgery and radiotherapy for symptomatic spinal metastases is more cost effective than radiotherapy alone: a cost utility analysis in a U.K. Spinal Center.World Neurosurg. 2018; 109: e389-e397
- Quality of life and cost-utility of surgical treatment for patients with spinal metastases: prospective cohort study.Int Orthop. 2017; 41: 1265-1271
- The cost-effectiveness of surgical intervention for spinal metastases: a model-based evaluation.J Bone Joint Surg Am. 2021; (Online ahead of print. PMID: 34288901)https://doi.org/10.2106/JBJS.21.00023
- Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score.Spine J. 2021; 21: 28-36
- Reflection on modern methods: Trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.Int J Epidemiol. 2020; 49: 1719-1729
- Regression Models for Categorical Dependent Variables Using STATA.2nd Edition. STATA Press, College Station, TX2006
Article info
Publication history
Footnotes
FDA device/drug status: Not applicable
Author disclosures: GXX: Nothing to disclose. JEC: Grants: OREF (F); MLF: Grants: OREF (F). AJS: Grants: OREF (F, paid directly to institution); Grants: NIH-NIAMS (G, paid directly to institution); Royalties: Wolters Kluwer (E); Royalties: Springers Nature (A); Grants: DoD (H, paid directly to institution).